SoftBank inks a deal to take control over 80% of WeWork ownership
By Nikita Chaurasia  Date: 2019-10-24

SoftBank inks a deal to take control over 80% of WeWork ownership

SoftBank has reportedly invested nearly USD 11 billion in workspace startup and real estate. In January, when the company decided to invest in WeWork, it did a valuation of around USD 47 billion. Since then, growing investor concern over WeWork’s business model and improper corporate control have drove WeWork’s possible valuation down significantly. The company decided to go public with a valuation of around $10 billion—ahead of ditching its plans for an IPO in 2019.

However, WeWork is now in headlines as SoftBank has taken control over its approx. 80% ownership. According to the real estate company, SoftBank will provide USD 5 billion in new financing and up to USD 3 billion in a tender offer for current shareholders. SoftBank will also get a move on its existing USD 1.5 billion financing commitment, said WeWork.

Masayoshi Son, Chairman and CEO, SoftBank, meanwhile said that the company believes that the world is transforming a way in which people work and WeWork is the torchbearer of this revolution. Son added that as WeWork shares the same vision, SoftBank has decided to double down on the company by offering considerable operational support and capital infusion. The company will also stay committed to WeWork, its member-consumers, its employees and landlords, he said.

Sources cite that WeWork will appoint Marcelo Claure, Chief Operating Officer, SoftBank, as the executive chairman of its board of directors. Former WeWork CEO, Adam Neumann will meanwhile become a “board observer” as the company is expanding the group of directors and taking voting control over his shares.

According to reports, SoftBank will give $1.7 billion to Neumann to step down as chairman and give up his voting rights. Co-CEOs Sebastian Gunningham and Artie Minson replaced Adam Neumann in September after he attracted scrutiny for his odd leadership style and conflicts of interest.

After Neumann’s exit, WeWork’s new leadership has successfully worked for getting the company back on track to growth, including exploring the sale of numerous businesses.

Source Credit - https://www.cnbc.com/2019/10/23/softbank-to-take-control-of-wework.html

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fractyl raises series E funding of USD 55 million for diabetes cure
Fractyl raises series E funding of USD 55 million for diabetes cure
By Nikita Chaurasia

Fractyl Laboratories raised series E funding of USD 55 million to continue financing the pivotal clinical trial of its potential non-surgical, non-drug treatment for Type 2 diabetes. As per the trusted sources, the capital will be invested on mass-b...

Nokia Corp. partners with IISc to improve telecommunication solutions
Nokia Corp. partners with IISc to improve telecommunication solutions
By Nikita Chaurasia

Finnish multinational telecommunications giant Nokia Corporation has recently made it to the headlines after entering into a joint venture agreement with IISc (Indian Institute of Science) to launch the Nokia CoE (Centre of excellence) for Networked ...

Motorola acquires Pelco Inc. to expand its video security services
Motorola acquires Pelco Inc. to expand its video security services
By Nikita Chaurasia

Chicago-based telecommunication company, Motorola Solutions Inc., has made it to the headlines through its acquisition of Pelco Inc. from Transom Capital Group for $110 million dollars. For those uninitiated, Pelco Inc. is a security and surveillanc...

NeuroRx, Relief Therapeutics declare results of RLF-100 clinical trials
NeuroRx, Relief Therapeutics declare results of RLF-100 clinical trials
By Nikita Chaurasia

U.S.-based pharmaceutical company NeuroRx Inc., along with Relief Therapeutics Holding AG, a Swiss drug development company, have reportedly declared that aviptadil (RLF-100) clinical trials have showcased quick recuperation of respiratory failures a...

Boehringer Ingelheim acquires GST to expand stem cell capabilities
Boehringer Ingelheim acquires GST to expand stem cell capabilities
By Nikita Chaurasia

Boehringer Ingelheim, a leader in pharmaceutical products, has recently made it to the headlines by acquiring Belgium-based veterinary biotech firm, Global Stem cell Technology (GST). According to reliable sources, the collaboration with GST will al...